Apatinib
Drug timelines are a Plus or Pro feature.
388 regulatory and trial events tracked for Apatinib, covering 2008-07-22 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Phase III Trial of Camrelizumab+Apatinib+Eribulin vs. Physician's Choice Chemotherapy in Advanced Triple-Negative Breast Cancer [Phase 3]